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The emphasis of this paper is the review of sev­
eral aspects of renal disease which have immunologic 
overtones and clinical relevance. The pathogenesis of 
several subtypes of glomerulonephritis will be dis­
cussed, the immunologic implications of amyloidosis 
will be noted, and the relation between immune 
mechanisms and tubulointerstitial disease will be men­
tioned. The discussion will then be completed by an 
analysis of the prognosis of the aforementioned renal 
diseases, and by an attempt to place contemporary 
therapeutic modalities in a proper perspective. 
Before treating each of these subjects, it is worth 
acknowledging the important contribution which 
evaluation of renal biopsy tissue has made to our 
understanding of the relation between immune mech­
anisms and renal disease. The availability of fresh 
tissue from biopsies in living patients has allowed 
adequate evaluation by immunoAuorescent micro­
scopy and electron microscopy (EM). Each of these 
techniques has provided important and com­
plementary information about the nature of fine 
structural damage induced by immune mechanisms.' 
Immune Complex Disease. 
Pro/ifera1ive G/omerulonephriris. 
Figure I is an immunoAuorescent stain for lgG 
in the glomerulus of a patient with acute post­
streptococcal glomerulonephritis. A Auorescin­
tagged antibody against lgG has been layered over a 
quick-frozen biopsy specimen and become attached 
to the lgG. The positive Auorescent lumps are 
thought to represent deposits of antigen-antibody 
Correspondence and reprint requests to Dr. William F. Falls. 
Jr .. Renal Section. McGuire VA Hospital. Richmond. Virginia 
23249. 
60 
complexes adjacent to the capillary basement mem­
branes and in the mesangium (the supporting stalk) 
of the glomerulus. It is assumed that these histologic 
abnormalities reAect the following series of path­
ogenic events: an antigenic derivative of the strepto­
coccus has entered the circulation: an antibody re­
sponse has developed: soluble immune complexes 
have been formed in a state of antigen excess: the 
complexes have precipitated in the glomerulus: com­
plement components have been fixed: and the com­
plement cascade activated with resultant production 
of inAammation and damage to the gomerulus. Un­
der certain circumstances immunoAuorescent stains 
may identify complexes containing lgM and lgA as 
well as various components of the complement sys­
tem and fibrinogen.' 
Figure 2 is a light microscopic view of a glomer­
u l us from another patient with acute post­
streptococcal glomerulonephritis. This picture is the 
light microscopic correlate of the immunoAuorescent 
preparation described above. The features of a dif­
fuse proliferative glomerulonephritis including swell­
ing of the tufts. a marked increase in cellularity (pri­
marily mesangial cells). occlusion of the capillary 
loops. and an inAux of polymorphonuclear leu­
kocytes are present. It is likely that the leukocytes 
have been attracted by leukotactic factors released by 
activation of the complement cascade.' 
Figure 3 is an EM preparation showing part of 
the ultrastructure of a glomerulus from the biopsy of 
a patient with poststreptococcal glomerulonephritis. 
The pathologic findings include fusion of the foot 
processes of the epithelial cells and deposition of 
large. electron-dense deposits adjacent to the sub­
endothelial surface of the basement membrane. It is 
thought that these deposits represent the immune 
complexes which have been discussed above. Post-
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Fig 1-lmmunofluorescent microscopic preparation (anti-lgG) or 
a portion or a glomerulus from a patient with poststreptococcal 
glomerulonephritis. Note the "lump-bumpy" pattern. (X 1500). 
streptococcal glomerulonephritis is characteristically 
associated with large "humplike" deposits in the sub­
epithelial position, but this finding is not absolutely 
diagnostic because a similar locus of depositon has 
been noted in other immune-complex-mediated renal 
diseases such as syphilis with nephritis.' 
Subsequently, it will become evident that im­
mune complexes may localize on either side of the 
basement membrane. The reason a deposit may lo­
cate in a given site (either subepithelial, sub­
endothelial, or intramembranous) is not entirely de­
fined. Current theory holds that the location of 
immune-complex deposits may depend upon their 
physical characteristics, with smaller deposits 
Fig 2-Light microscopic preparation (H & E) or a portion or a 
renal biopsy from a patient with diffuse prolirerative glomerulo­
nephritis following a streptococcal inrection (X 200). 
Fig )-Electron microscopic preparation or a portion or a glome­
rulus from a patient with acute poststreptococcal glomeruloneph­
ritis. Note the large subepithelial electron-dense deposit. "hump" 
( X 32.000). 
(formed by combination of antigen with low affinity 
antibody) localizing in a subepithelial site and large 
complexes localizing subendothelially.' There is also 
evidence to suggest that complement-binding sites 
may be present in the region of the epithelial cell foot 
processes.' Complexes which have fixed complement 
prior to traversing the basement membrane may be 
snared by attachment of complement with these re­
ceptors. 
Figure 4 is the light microscopic view of two 
glomeruli from a patient with a staphylococcal albus 
Fig 4-Light microscopic preparation (H & E} or a portion or a 
renal biopsy rrom a patient with "shunt nephritis" secondary to 
staphylococcal inrection. Note that glomerulus in the center and 
the portion or the glomerulus at the lower margin both show 
prolirerative changes ( x 200). 
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Fig 5-Electron microscopic preparation of a portion of a glome­
rulus from a patient with systemic lupus erythematosus and a 
diffuse proliferative lesion by light microscopy. Note the large 
subendothelial deposits (X 10.000). 
infection of a ventriculojugular shunt which had been 
made because of hydrocephalus. The lesion is a dif­
fuse proliferative glomerulonephritis and could not 
be distinguished from the poststreptococcal lesion by 
conventional light microscopic or immunofluores­
cent studies. Figure 5 is an EM study showing a large 
subendothelial deposit from a patient with lupus er­
ythematosus and proliferative glomerulonephritis by 
light microscopy. The subendothelial region is the 
favored site of deposition in lupus. 1 Figure 6 shows 
the light microscopic appearance of a glomerulus 
from a patient with focal proliferative glomerulo­
nephritis. Note that segments of the glomerular tuft 
Fig 6-Light microscopic preparation (H & E) of a portion of a 
renal biopsy from a patient with systemic lupus erythematosus 
showing a focal proliferative lesion (X 400). 
appear to have normal cellularity and that the in­
flammatory reaction is less severe than in the cases 
noted earlier. lmmunofluorescent and electron mi­
croscopic studies would show the immune deposits to 
be less numerous and to have more of a mesangial 
location than in the diffuse proliferative lesion. IgA 
deposition is seen with greater frequency in the mes­
angium in focal lesions. 1 
After a review of the first six figures it is clear 
that the classic light microscopic picture of pro­
liferative glomerulonephritis, either diffuse or focal, 
reflects a disorder of immune-complex deposition in 
the region of the glomerular capillary basement mem­
brane and mesangium. From observation of the path­
ologic material it is also easy to envision that the 
inflammatory process would lead to leakage of albu­
min, red blood cells, and immunoproteins into the 
urine with development of an "active" urine sedi­
ment. The mediators of inflammation in proliferative 
lesions are not well understood but are thought to be 
released by activation of the terminal portion of the 
complement cascade. 1 Serum levels of early-reacting 
complement components and C, are frequently, but 
not invariably, reduced in patients with immune­
complex-mediated proliferative lesions. The antigenic 
substances which may be involved in this type of 
lesion are numerous and will be discussed below. 
Membranous Glomerulonephri1is. 
Another histologic pattern of renal involvement 
that is almost certainly mediated by glomerular im­
mune-complex deposition is membranous glomerulo­
nephritis (Fig 7). Note that the only abnormality is 
marked thickening of the capillary basement mem-
Fig 7-Light microscopic preparation (PAS) of a portion of a 
glomerulus from a patient with membranous glomerulonephritis 
(X 200). 
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brane. Figure 8 demonstrates that the cause of the 
basement membrane thickening is the presence of 
numerous dense deposits along the epithelial border 
of the basement membrane with projections of base­
ment membranelike material interposed between the 
deposits. Fusion of the epithelial cell foot processes 
adds to the breadth of the capillary wall and probably 
has been induced by the marked albumin leak which 
most of these patients experience. lmmunofluores­
cent studies show a fine granular deposition of IgG 
and IgM as would be expected from the location of 
the deposits on EM.' On occasion. complement com­
ponents also may be identified in the glomerular ca­
pillaries, but this occurs with much less frequency 
and in a more scant distribution than in proliferative 
lesions. Serum complement levels are usually normal 
in membranous glomerulonephritis. The absence of 
an inflammatory response may relate to the presence 
of immune complexes which fix complement poorly, 
or to an impotent complement system. As might be 
expected, patients with the membranous lesion usu­
ally develop a nephrotic syndrome and tend to have a 
less "active" sediment than those with a proliferative 
process. 
Antigens Associated with Immune Complex Dis­
ease. 
There are a large number of disorders in which 
antigen-antibody complex deposition is recognized or 
suspected as being the cause of renal disease.' Ex­
ogenous antigens, particularly drugs and foreign pro­
teins, may induce an immune-complex glomerulo­
nephritis with the appearance of either a proliferative 
Fig 8-Electron microscopic preparation of a portion of a glome­
rulus from a patient with membranous glomerulonephritis. Note 
the numerous subepithelial deposits. ( x 15,800). 
or a membranous lesion. A number of bacterial or­
ganisms including the streptococcus, staphylococcus, 
pneumococcus, and treponema pallidum have in­
duced a complex-mediated nephritis which is usually 
proliferative in pattern. Plasmodium malariae may 
cause either a proliferative or membranous nephritis. 
It is suspected that numerous viral agents may incite 
immune-complex-mediated renal disease. Both hepa­
titis-B virus and the Barr-Epstein virus have been 
clearly identified as providing the antigenic stimulus 
for an immune-complex-mediated disorder. The for­
mer has been incriminated as inducing proliferative 
and membranous lesions as well as a generalized 
arteritis. 
Perhaps the best defined of all immune-complex­
mediated renal diseases is that associated with sys­
temic lupus erythematosus. It is clear that in this 
disorder endogenous cellular antigen (DNA, RN A, 
and numerous derivative substances) provides an in­
exhaustible source of antigen for complex formation. 
Diffuse proliferative, focal proliferative, and mem­
branous nephropathy have been identified in patients 
with systemic lupus. 
Recently, considerable excitement has been gen­
erated by the discovery of other endogenously-pro­
duced antigens which may cause renal disease in man. 
A derivative of tubular brush border has been identi­
fied as the antigenic component of an immune-com­
plex-induced membranous glomerulonephritis in pa­
tients with sickle cell anemia.' The nephrotic 
syndrome secondary to a membranous lesion has 
been recognized in some patients with solid tumors of 
the lung and colon: in a patient with the latter neo­
plasm carcinoembryonic antigen has been identified 
as part of the complex on the basement membrane.• 
Immune-complex glomerulonephritis may be seen 
with some frequency in patients with cryoglobuli­
nemia, particularly those in whom there is a mixed 
IgG-IgM cryoglobulin with rheumatoid factor activ­
ity.• 
After reviewing all of the known causes of im­
mune-complex-mediated renal disease one is left with 
an unrecognized antigen as the stimulus for the dis­
ease process in most cases of the idiopathic nephrotic 
syndrome. This includes patients with focal pro­
liferative, diffuse proliferative, or membranous le­
sions. The offending antigen is also unknown in such 
syndromes as Wegener's granulomatosis and He­
noch-Schonlein purpura. Within the next few years 
the inciting antigens will be identified in many of 
these disorders and may well prove to be viral agents. 
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Fig 9-lmmunofluorescent preparation (lgG) from a portion of a 
biopsy of a patient with anti basement membrane antibody disease. 
Note the linear pattern of fluorescence (X 1500). 
Antibasement Membrane Antibody Disease. 
Figure 9 is an immunofluorescent stain showing 
homogeneous linear deposition of IgG along the 
basement membrane of the glomerulus. This pattern 
is thought to represent the attachment of antibase­
ment membrane antibody to some antigenic com­
ponent in the basement membrane. The antibody is 
usually lgG although linear deposition of IgM and 
complement have also been described in some cases. 
In many patients, circulating antibody can be demon­
strated by allowing the patient's serum to react with 
sections of normal human kidney. The mechanism 
whereby deposition of antibasement membrane an­
tibody leads to renal damage is uncertain, but that 
severe damage can be induced is amply demonstrated 
by Figure 10 which shows a proliferative lesion of 
both the mesangial and epithelial cells. Proliferation 
of the latter with crescent formation is apparently 
induced by the leakage of large molecular weight 
fibrin precursors into Bowman's space through tears 
in the basement membrane. 1 
An occasional epithelial crescent can be found in 
virtually any type of renal disease, but involvement of 
essentially the entire glomerular population is seen in 
two circumstances: rapidly progressive glomerulo­
nephritis and Goodpasture's syndrome. Many pa­
tients with the clinical picture of idiopathic, rapidly 
progressive glomerulonephritis and most patients 
with Goodpasture's syndrome (lung hemorrhage and 
nephritis) will display evidence of antibasement 
membrane antibody as the cause of renal damage. 
The offending antibody in Goodpasture's syndrome 
cross-reacts with pulmonary basement membrane 
and is thought to induce the pulmonary as well as the 
renal disease. The stimulus for production of anti­
basement membrane antibody is uncertain, but dam­
age to pulmonary or glomerular basement membrane 
by viral agents or chemical irritants with uncovering 
of hidden antigenic sites has been suggested as a 
mechanism. 1 As might be expected, patients with an­
tibasement membrane antibody disease and crescent 
formation frequently have very "active" urine sedi­
ments and may be nephrotic. 
Glomerulonephritis and Activation of the Alter­
nate Complement Pathway ( Membranoproliferative 
Glomerulonephritis). 
In general terms. when the complement system is 
activated in the disorders discussed above. it is prob­
ably brought about by the classic pathway (C i � C, 
� C, � C,). Recently. however. evidence has begun 
to accumulate suggesting that activation of the latter 
part of the complement cascade via the so-called 
"alternate pathway" may be of importance in in­
ducing renal damage. 1 Activation of the "alternate 
pathway" has been noted in some cases of post­
streptococcal glomerulonephritis. but the most pro­
vocative evidence for a role of this pathway has been 
observed in patients with the pattern of membrano­
proliferative or mesangiosclerotic glomeruloneph­
ritis. 
West and his associates originally described a 
group of children with heavy proteinuria: "active" 
urine sediments: low circulating C, levels: light m1-
Fig 10-LighI microscopic preparation (H & E) from the renal 
biopsy of a patient with antihascmcnt membrane antibody disease. 
otc the marked crescent formation and interstitial inflammatory 
reaction (X 80). 
FALLS: IMMUNOLOGY AND DISEASES OF THE KIDNEY 65 
croscopic evidence of cellular proliferation, increased 
mesangial matrix, and a tendency to lobulation of the 
glomerular tufts: glomerular C, deposition with little 
or no accompanying IgG or lgM by immunofluores­
cence: and a circulating activator of C, (C, nephritic 
factor).• The patients were considered to be a unique 
group and designated as having membranoprolifera­
tive glomerulonephritis with hypocomplementemia. 
Subsequently, it has been recognized that patients 
with membranoproliferative lesions are not a homo­
geneous group: and they have now been subdivided 
into two groups, primarily on the basis of EM fea­
tures. Type I patients show evidence of splitting and 
reduplication of the basement membrane and have 
electron dense deposits. The activation of early com­
plement components and the infrequent demonstra­
tion of circulating C, nephritic factor in this group 
suggest the presence of a classic immune-complex­
mediated disease. Type II patients, on the other hand, 
show a marked homogeneous increase in density of 
the glomerular capillary basement membrane with­
out evidence of deposits ( dense deposit disease).' Cir­
culating C, nephritic factor is usually present and 
early reactive complement components are normal. 
The nature of the dense transformation of the base­
ment membrane is uncertain and the pathogenesis of 
this disorder remains to be defined. 
Lipoid Nephrosis of Childhood (Nil Disease). 
Another disorder which classically has been con­
sidered with the glomerulonephritides is lipoid neph­
rosis of childhood or nil disease. This is the most 
common cause of the nephrotic syndrome in child­
hood. The only recognizable histologic abnormality 
in patients with this disturbance is fusion of the foot 
processes recognizable on EM (Fig 11 ). The etiology 
of this disorder is uncertain, but renewed interest in 
the possibility of its being an immunologic disease 
has been kindled by the discovery of a similar lesion 
in several patients with Hodgkin's disease who have 
the nephrotic syndrome. Since current thought sug­
gests that Hodgkin's disease may be a T-cell distur­
bance, it has been suggested that nil disease reflects a 
disturbance of cellular immunity.• 
Focal Segmental Sclerosis. 
A subgroup of children with the idiopathic neph­
rotic syndrome who do not respond well to the thera­
peutic agents mentioned below has been described 
recently. This group frequently has mild microscopic 
hematuria as opposed to the children with typical nil 
Fig I I-Electron microscopic preparation of a portion of a renal 
biopsy from a patient with .. nil disease.·· Note the normal appear­
ing basement membrane. the absence of deposits. and the presence 
of fused foot processes (X 14.000). 
disease who show no "activity" of the urinary sedi­
ment. Segmental sclerosis beginning in the juxtame­
dullary glomeruli and progressing to become a dif­
fuse generalized involvement with ultimate global 
sclerosis has been identified in these children. 
Amyloidosis. 
Amyloidosis of the kidney is an interesting cause 
of the nephrotic syndrome which, on clinical 
grounds, may be confused with the glomerular dis­
eases previously mentioned and which has a close 
relationship to the body's immune systems. On light 
microscopy the glomerular mesangium may appear 
infiltrated with a homogeneous material and the 
basement membrane may be thickened. Such a pat­
tern may be confused with diabetic nephropathy or a 
late stage of immune-complex-mediated nephropathy 
which has led to significant sclerosis: staining with 
Congo red and viewing the sections under polarized 
light will demonstrate the typical apple-green 
birefringence if amyloid fibrils are present. however. 
The amyloid fibril also gives a characteristic appear­
ance by EM as demonstrated in Figure 12. 
Exciting recent work has provided a clearer un­
derstanding of the nature of amyloid. The amyloid 
fibrils seen in patients with B-cell dyscrasias, either 
multiple myeloma or primary amyloidosis, are 
thought to be composed of light-chain derivatives of 
the paraprotein produced by the abnormal B cells.'0 
An entirely unique protein (AA protein) has been 
identified as composing the amyloid of patients with 
secondary amyloidosis related to chronic infection or 
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familial Mediterranean fever. 10 The reason that these 
different proteins have similar refractive properties 
and give a similar appearance on EM relates to the 
fact that they share the same beta-pleated arrange­
ment of their amino acid components. 
Tubulointerstitial Disease. 
Investigation of the immunologic aspects of 
tubulointerstitial disease has been overshadowed by 
the tidal wave of studies evaluating the mechanisms 
of immunologic glomerular damage. Interest in the 
interstitium has been rekindled, however, by the dis­
covery of an association between the ingestion of 
certain drugs and the development of interstitial 
nephritis. It is now evident that a molecular moiety of 
several members of the penicillin family may act as a 
hapten, combine with an endogenous protein to 
make a complete antigen, stimulate an antibody re­
sponse, and ultimately result in precipitation of im­
mune complexes in the region of the tubular base­
ment membranes with incitement of a diffuse 
interstitial inflammatory reaction." A utoantibodies 
to tubular basement membrane have also been dem­
onstrated and incriminated as the cause of interstitial 
infiltration in lupus erythematosus, the transplanted 
kidney, and the crescentic disease of Goodpasture's 
syndrome and rapidly progressive glomerulonephritis 
(Fig 10).' Studies in animals have suggested that 
chronic pyelonephritis may be perpetuated by cellu­
lar immune mechanisms originally activated by the 
release of antigenic substances from tissues damaged 
by invading pathogenic bacteria.' 
Prognosis and Treatment. 
Having reviewed the current thoughts about the 
pathogenesis and histologic appearance of immuno­
logically related renal disease, we ought now to at­
tempt to apply this information in a fashion that will 
be beneficial to a given patient. Such application 
is practical in two major areas, prognosis and treat­
ment. The importance of a renal biopsy in obtain­
ing tissue for evaluation is obvious. Its importance in 
obtaining practical prognostic and therapeutic infor­
mation which will help the patient is variable. For 
example, a renal biopsy is not likely to be helpful in 
the management of the patient with obvious inter­
stitial disease as manifested by leukocytes and a rela­
tively scant amount of albumin in the urine. If the 
disease is drug induced, it will probably resolve spon­
taneously with discontinuation of the offending agent. 
Fig 12-Electron microscopic preparation of a portion of a glome· 
rulus showing amyloid fibrils (X 24.000). 
It is among patients with an unexplained nephrotic 
syndrome that evaluation of an adequate renal 
biopsy is most helpful. 
Prognosis. 
Patients with focal proliferative glomerulone­
phritis. lipoid nephrosis. and membranous glome­
rulonephritis have a relatively good prognosis either 
treated or untreated. Lupus patients with a focal 
proliferative lesion may live for years without show­
ing evidence of deterioration in renal function. Many 
children with nil disease undergo a spontaneous re­
mission and when deterioration in function occurs. it 
usually progresses very slowly. Patients with drug­
related or tumor-related membranous nephropathy 
may have remission of their disease with removal of 
the offending antigen: those with an idiopathic mem­
branous lesion, or lupus and a membranous lesion. 
may spontaneously remit or remain nephrotic with 
an unchanged creatinine clearance for years.' 
On the other hand. patients with diffuse pro­
liferative lesions unrelated to a specific infecting or­
ganism, particularly those with lupus erythematosus. 
have a poor prognosis. Most patients with antibase­
ment membrane antibody disease and marked cres­
cent formation will reach the terminal stage within 
two years. 
Patients with membranoproliferative glomerulo­
nephritis tend to have an intermediate prognosis with 
most showing progressive deterioration in renal func­
tion to its terminal stage in 5 to 12 years.' Amyloid 
patients and patients with segmental sclerosis also 
demonstrate an intermediate prognosis. 
As knowledge accumulates. we may feel obliged 
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to perform a biopsy on every patient with chronic 
renal disease who is progressing toward its terminal 
stage in order to determine his or her ultimate can­
didacy as a transplant recipient. Antibasement mem­
brane antibody disease, membranoproliferative 
glomerulonephritis, and focal segmental sclerosis 
have been recognized as recurring in grafted kidneys, 
ultimately leading to their failure. Indeed, it is now 
considered inappropriate to transplant a patient with 
antibasement membrane antibody disease if circulat­
ing antibodies can be demonstrated in his or her 
serum. 1 
Treatment. 
Much has been written about the treatment of 
immunologically related renal diseases. Unfortu­
nately, except for the management of two disorders, 
nil disease and Wegener's granulomatosis, there is 
little agreement and much bias about specific treat­
ment. Diuretics are of great symptomatic value in 
edematous states but have no effect on basic path­
ogenic mechanisms. The agents which have been used 
as possible inhibitors of immune mechanisms include 
corticosteroids, antimetabolites, and alkylating 
agents. Each of these drugs has significant toxicity, 
particularly when used over a prolonged period, and 
their modes of action remain uncertain. The natural 
history of many of the immunologically related renal 
diseases is variable and capricious. Consequently, 
controlled studies, involving numerous patients and 
extending over a long period of time, are needed to 
establish the efficacy of any drug regimen. These 
studies have not been done. Outlined below is a per­
sonal assessment of the state of the art of immuno­
therapy in renal disease. 
As already mentioned there seems to be uniform 
agreement that therapy is effective in those patients 
with nil disease and those with Wegener's gran­
ulomatosis. In lipoid nephrosis the administration of 
corticosteroids will enhance the rate of remission, 
and the duration of remission after relapse can be 
prolonged by supplementing the steroids with cy­
clophosphamide or chlorambucil. Nil disease in 
Hodgkin's disease will subside with treatment of the 
lymphoma. Cyclophosphamide is effective in produc­
ing a sustained remission in the renal disease of 
Wegener's granulomatosis, a disorder which was for­
merly uniformly lethal.12 
Treatment in a patient with immune-complex­
mediated diffuse proliferative or focal glomerulo­
nephritis is most effective if it can be directed at 
eradication of a recognizable inciting antigen. Ob­
viously, this is most successful if the antigen is de­
rived from an infectious agent such as a staphylococ­
cus or a spirochete. If the antigen cannot be removed 
as in lupus erythematosus, one must carefully weigh 
the potential benefits of therapy against the possi­
bility of significant drug toxicity. It is my impression 
that most authorities would tend not to treat a focal 
proliferative lesion in lupus but would be aggressive 
in the management of a patient with a diffuse pro­
liferative lesion. In the latter case, one might use a 
combination of steroids and either azothioprine or 
cyclophosphamide in doses sufficient to return sero­
logic indicators of disease activity such as C, levels or 
anti-DNA antibody levels to normal. 13 
The management of membranous glomerulo­
nephritis of either the idiopathic type or that asso­
ciated with lupus erythematosus is equally per­
plexing. Controlled studies done in Great Britain in 
the 60s suggested that no therapy was effective in the 
idiopathic membranous lesion." However, recent un­
controlled retrospective analysis16 · 16 and an ongoing 
American cooperative study17 suggest that prolonged 
steroid administration may be helpful. 
Therapy for patients with crescentic disease has 
included steroids, azothioprine, cyclophosphamide, 
and anticoagulation agents. Isolated cases treated 
with these agents have shown good responses, but 
there have been no controlled studies to substantiate 
this fact. Steroids have been advocated as being of 
value in membranoproliferative lesions, 1• but here 
again there have been no comparisons with a com­
parable untreated population. 
There seems to be no specific treatment for am­
yloidosis. However, amyloid deposition may be in­
hibited by treatment of an underlying myelomatous 
state or by correction of a smoldering infectious proc­
ess.' Success has been reported recently in reducing 
proteinuria in amyloid disease secondary to familial 
Mediterranean fever by the administration of colchi­
cine.'0 
Summary. 
The relation between the immunologic systems 
and renal disease has been brieAy reviewed and sev­
eral pathogenic immunologic mechanisms have been 
correlated with the histologic pictures which they 
produce; this information has then been related to 
contemporary thoughts about prognosis and therapy. 
Much has been learned, but there is obviously much 
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more to be done, particularly in the areas of pre­
vention and treatmenf. 
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